How long can a patient with chronic myeloid leukemia live?
Diseases caused by abnormalities in hematopoietic stem cells—such as uncontrolled malignant cell proliferation, dysregulated cell growth, impaired apoptosis, and suppression of normal bone marrow hematopoiesis. So, how long can patients with chronic myeloid leukemia (CML) live?
How long can patients with chronic myeloid leukemia live?
In the past, without effective treatment, patients diagnosed with CML typically survived approximately three years, and rarely exceeded five years. Due to the lack of effective therapies, the disease often progressed to acute leukemia within three years—a condition that is difficult to control and treat. Consequently, the disease course was usually short, placing patients at high risk of mortality. Today, however, with the advent of novel targeted therapies and allogeneic hematopoietic stem cell transplantation (allo-HSCT), many CML patients achieve long-term survival.

CML typically progresses through three distinct phases: 1. The chronic phase—duration varies among individuals but averages about three years. 2. The accelerated phase—often begins after approximately three years and lasts only several months. 3. The blast (acute) phase—characterized by rapid transformation from chronic-phase CML into acute leukemia (also termed “blast crisis”).

First, avoid exposure to harmful substances in daily life—including toxic chemicals and ionizing radiation. Individuals working long-term with chemical raw materials or radioactive substances must strictly adhere to occupational safety guidelines and implement appropriate personal protective measures to prevent indoor environmental contamination. We hope this information is helpful to you!